ArticleBMC cancer2021

Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol.

Jeremie Calais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.